Contact Us

Why Population Omics

Health systems are built to treat illness. Population omics changes that

Almost all healthcare expenditure globally goes toward illness management. Non-communicable diseases account for 75% of deaths worldwide. Rare diseases affect over 300 million people. And the prevention gap continues to grow. The health systems of tomorrow need a different foundation, one built on biological understanding, early prediction, and proactive intervention. Population omics is that foundation.

Test Tube (1).svg

Healthcare spend on illness management

97

%
DNA.svg

Spent on prevention

3

%
Hexagon (1).svg

Global deaths from NCDs

75

%
Circle Cells Outline.svg

People living with rare diseases

300

M+

Source: OECD Health at a Glance 2025, OECD Publishing, Paris (2025)

Our Population Omics Model

What Biogenix Delivers

Biogenix enables governments and health systems to build omics-driven strategies for precision health, disease prevention, and a thriving life sciences economy.

Population omics gives health systems the biological foundation to predict risk before symptoms appear, prevent disease before it develops, and personalise treatment when it is needed. That shift from reactive to proactive health is only possible with omics infrastructure at its core

Biogenix delivers that infrastructure as a complete, end-to-end service. From sequencing and clinical translation to data governance, citizen engagement, and pharma partnership development, our model covers every dimension of building a sustainable, omics-driven national health system.

Proven at Scale

We have built it, delivered it, and proven it works. We can do the same for you.

Our delivery model has been designed, built, and refined through operating one of the world's most advanced national omics programs. We bring a tested blueprint, proven operational capability, and a track record that no other omics organisation can match. Everything we deliver has been validated in a live, integrated health system — and is now available to governments and health systems worldwide.

Building a Learning Health System

A national omics program is not a project. It is the foundation of a health system that predicts, prevents, and continuously improves.

The problem with reactive health systems is not just cost. They do not learn. Every patient treated is a data point lost. Biogenix builds population omics infrastructure that changes that logic. Every genome sequenced deepens biological understanding. Every clinical insight strengthens care. Every discovery informs the next breakthrough. And every outcome feeds back into research and innovation, creating a health system that gets smarter, more preventive, and more economically sustainable over time.

Omics in Practice

See what a national omics program looks like when it is built, operational, and delivering results.

The Three Pillars

Key Milestones and Strategic Initiatives Delivered by M42

  • 01

    Population scale pharmacogenomics deployment of 160K

  • 02

    Pre-marital screening: over 17K individuals screened

  • 03

    Provided WGS diagnostics access to national population

  • 04

    Newborn Screening covering 890+ actionable diseases

  • 05

    Mapping at population scale genetic variants for vision loss

  • 01
  • 02
  • 03
  • 04
  • 05
  • 06
  • 07
  • 08
  • 09
  • 10

Clinical Agenda

Economic Development Agenda

Research Agenda

  • 06

    Validated breast cancer PRS models in Emirati population

  • 07

    Using methylation to predict aging biomarkers

  • 08

    Cutting-edge research with 8 papers published in ASHG

  • 09

    Initiating engagements with pharma to unlock value

  • 10

    Exploring biotech engagement to complement pharma engagement

Download related cutting-edge research -
White Papers & Though Leadership